Bio-Techne
TECH
#1830
Rank
$11.43 B
Marketcap
$72.81
Share price
0.04%
Change (1 day)
26.71%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Number of shares outstanding for Bio-Techne (TECH)

Number of shares outstanding as of November 2026 : 156,090,000

According to Bio-Techne's latest financial reports and stock price the company's current number of shares outstanding is 156,090,000. At the end of 2024 the company had 157,309,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Bio-Techne from 2022 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.15 B-0.14%
20230.15 B0.33%
20220.15 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Thermo Fisher Scientific
TMO
370,000,000 137.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
274,788,000 76.04%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
1,035,000,000 563.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
703,800,000 350.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
206,346,000 32.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
52,403,000-66.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
26,746,000-82.87%๐Ÿ‡บ๐Ÿ‡ธ USA